Glossary
Definitions of terms and regulations
There are currently 15 glossary in this directory beginning with the letter I.
I
immunosuppressants
Medications that suppress the immune system to prevent it from attacking transplanted organs, treating autoimmune disorders, or preventing rejection of transplanted tissue. These medications can also increase the risk of infection and certain types of cancer.
infectious disease
Illnesses caused by bacteria, viruses, or fungi that enter the body, multiply, and can cause an infection.
inflammation
A natural process in the body that is characterized by redness, swelling, warmth, pain, and sometimes loss of function. It is the body's response to injury, infection, or irritation, and involves a complex network of cells and chemicals that work together to protect the body from harmful stimuli.
innate immunity
Innate, or nonspecific, immunity is the defense system with which you were born. It protects you against all antigens. Innate immunity involves barriers that keep harmful materials from entering your body.
institutional review board (IRB)
A group that has been formally designated to review and monitor biomedical research involving human subjects.
insulin
A hormone produced by the pancreas that regulates the level of glucose in the blood. Insulin helps glucose to enter the body's cells, where it is used for energy or stored for future use. In people with diabetes, the body either does not produce enough insulin or does not respond to it properly, leading to high blood sugar levels.
integumentary system
The outer covering of a mammal’s body, including skin, hair, and nails, claws, or hooves.
intrathecal
The fluid filled space between the thin layers of tissue that cover the brain and spinal cord.
investigational new drug (IND)
A substance that has been tested in the laboratory and has been approved by the U.S. Food and Drug Administration (FDA) for testing in people. Clinical trials test how well investigational new drugs work and whether they are safe to use. An investigational new drug may be approved by the FDA for use in one disease or condition but still be considered investigational in other diseases or conditions. Also called experimental drug, IND, investigational agent, and investigational drug.

We cannot do
this alone
Together we are changing the world—
one patient at a time
We hope that you join us on this journey to discover, develop and provide individualized antisense medicines for free for life for nano-rare patients. The ultimate personalized medicine approach – for free, for life.
Follow us on social for updates on our latest efforts